133 related articles for article (PubMed ID: 19819717)
41. Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas.
Mao X; Orchard G
Br J Dermatol; 2008 Jul; 159(1):145-51. PubMed ID: 18460027
[TBL] [Abstract][Full Text] [Related]
42. Pediatric primary cutaneous marginal zone lymphoma: in association with chronic antihistamine use.
Sroa N; Magro CM
J Cutan Pathol; 2006 Sep; 33 Suppl 2():1-5. PubMed ID: 16972944
[TBL] [Abstract][Full Text] [Related]
43. Occurrence of Hodgkin's disease and cutaneous B-cell lymphoma in the same patient: a report of two cases.
Servitje O; Martí RM; Estrach T; Palou J; Gallardo F; Limón A; Romagosa V
Eur J Dermatol; 2000; 10(1):43-6. PubMed ID: 10694298
[TBL] [Abstract][Full Text] [Related]
44. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
45. Somatic hypermutation and B-cell lymphoma.
Dunn-Walters D; Thiede C; Alpen B; Spencer J
Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):73-82. PubMed ID: 11205334
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG;
J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713
[TBL] [Abstract][Full Text] [Related]
47. Cutaneous Ki-1 lymphoma: pathology, immunology and clinical characteristics.
Kadin ME
Princess Takamatsu Symp; 1987; 18():187-95. PubMed ID: 3506541
[TBL] [Abstract][Full Text] [Related]
48. Pseudolymphoma to Lymphoma: A Case of Chronic Reactive Lymphoid Hyperplasia Transforming to Primary Cutaneous Marginal Zone Lymphoma.
Singh N; Fagan KK; Patel RT; Grider DJ
Am J Dermatopathol; 2023 Apr; 45(4):250-253. PubMed ID: 36806052
[TBL] [Abstract][Full Text] [Related]
49. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.
Montalban C; Norman F
Expert Rev Anticancer Ther; 2006 Mar; 6(3):361-71. PubMed ID: 16503853
[TBL] [Abstract][Full Text] [Related]
50. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.
Sah A; Barrans SL; Parapia LA; Jack AS; Owen RG
Am J Hematol; 2004 Apr; 75(4):195-9. PubMed ID: 15054808
[TBL] [Abstract][Full Text] [Related]
52. A case report of primary cutaneous marginal zone lymphoma treated with intralesional steroids.
Kollipara R; Hans A; Hall J; Lisle A
Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437162
[TBL] [Abstract][Full Text] [Related]
53. Primary cutaneous marginal-zone lymphoma.
Farhadian J; Terushkin V; Meehan SA; Latkowski JA
Dermatol Online J; 2016 Dec; 22(12):. PubMed ID: 28329553
[TBL] [Abstract][Full Text] [Related]
54. Paediatric primary cutaneous marginal zone B-cell lymphoma: does it differ from its adult counterpart?
Amitay-Laish I; Tavallaee M; Kim J; Hoppe RT; Million L; Feinmesser M; Fenig E; Wolfe MEL; Hodak E; Kim YH
Br J Dermatol; 2017 Apr; 176(4):1010-1020. PubMed ID: 27501236
[TBL] [Abstract][Full Text] [Related]
55. A case of cutaneous blastic plasmacytoid dendritic cell neoplasm.
Xue R; Wu T; Pan H; Gu Y; Yang B; Chen Y; Qiu J
Acta Derm Venereol; 2010 Nov; 90(6):645-6. PubMed ID: 21057756
[No Abstract] [Full Text] [Related]
56. Pediatric Primary Cutaneous Marginal Zone Lymphoma Treated With Doxycycline.
Chan GC; Kamath S
Cutis; 2023 Nov; 112(5):E1-E4. PubMed ID: 38091439
[TBL] [Abstract][Full Text] [Related]
57. [The study on the specific eruptions of malignant lymphoma. II. Clinical and pathological interesting points, electron microscopic study, immune state and treatment].
Iijima S
Nihon Hifuka Gakkai Zasshi; 1990 Jun; 100(7):779-92. PubMed ID: 2214243
[TBL] [Abstract][Full Text] [Related]
58. Primary cutaneous marginal zone lymphoma treated with doxycycline in a pediatric patient.
Jothishankar B; Di Raimondo C; Mueller L; Zain J; Parekh V; Abdulla F
Pediatr Dermatol; 2020 Jul; 37(4):759-761. PubMed ID: 32323885
[TBL] [Abstract][Full Text] [Related]
59. Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma.
Maurus K; Appenzeller S; Roth S; Kuper J; Rost S; Meierjohann S; Arampatzi P; Goebeler M; Rosenwald A; Geissinger E; Wobser M
J Invest Dermatol; 2018 Jul; 138(7):1573-1581. PubMed ID: 29481902
[TBL] [Abstract][Full Text] [Related]
60. Primary Cutaneous B-Cell Lymphoma in Young Monozygotic Twins: A Case Report.
Bahig H; Petrogiannis-Haliotis T; Pehr KL; Roberge D
J Cutan Med Surg; 2016 Nov; 20(6):582-585. PubMed ID: 27358311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
